Taken together, the T cell transcriptome at a single‐cell level revealed an elevated cell activation, expansion, and IFN‐γ‐based anti‐tumour immunity in AL patients receiving repeated cycles of Dara ‐based therapy. The gene discussed is IFNG; the disease is neoplasm.